Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Clinical trial NCT05751733 · RECRUITING
Trial details
- NCT number
- NCT05751733
- Sponsor
- Xiangya Hospital of Central South University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2026-01-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.